PACCI Program
PACCI Program
Explore linked clinical trials.3 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| EBOla Post-Exposure Prophylaxis | Ebola hemorrhagic fever, Filoviridae infectious disease, Infections, Mononegavirales infectious disease, RNA Virus Infections, viral hemorrhagic fever, viral infectious disease | Not yet recruiting | Phase 3 | 2026-01-22 | NCT06841614 | |
| Impact of Delay Between Administration of Inmazeb Administration and Vaccination by Ervebo on Vaccine Immune Response on Healthy Volunteers | Ebola hemorrhagic fever, Filoviridae infectious disease, Infections, Mononegavirales infectious disease, RNA Virus Infections, viral hemorrhagic fever, viral infectious disease | Not yet recruiting | Phase 2 | 2026-01-22 | NCT05202288 | |
| Lassa Fever Clinical Course and Prognostic Factors in Nigeria | Arenaviridae infectious disease, Coma, Consciousness Disorders, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Infections, Lassa fever, Male Urogenital Diseases, Neurobehavioral Manifestations, Neurologic Manifestations, Pathological Conditions, Signs and Symptoms, RNA Virus Infections, Signs and Symptoms, Unconsciousness, Urogenital Diseases, acute kidney injury, kidney disorder, kidney failure, nervous system disorder, pregnancy disorder, urinary system disorder, viral hemorrhagic fever, viral infectious disease | Active, not recruiting | Not stated | 2025-01-29 | NCT03655561 |